Tzvi Palash
2016
In 2016, Tzvi Palash earned a total compensation of $336.6K as Chief Operating Officer at Protalix BioTherapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Option Awards | $46,945 |
|---|---|
| Salary | $206,828 |
| Stock Awards | $8,845 |
| Other | $74,016 |
| Total | $336,634 |
Palash received $206.8K in salary, accounting for 61% of the total pay in 2016.
Palash also received $46.9K in option awards, $8.8K in stock awards and $74K in other compensation.
Rankings
In 2016, Tzvi Palash's compensation ranked 12,393rd out of 14,075 executives tracked by ExecPay. In other words, Palash earned more than 12.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,393 out of 14,075 | 12th |
Division Manufacturing | 4,853 out of 5,486 | 12th |
Major group Chemicals And Allied Products | 1,728 out of 1,900 | 9th |
Industry group Drugs | 1,406 out of 1,543 | 9th |
Industry Biological Products, Except Diagnostic Substances | 258 out of 287 | 10th |
Source: SEC filing on March 16, 2017.
Palash's colleagues
We found four more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2016.
2016
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2016
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2016
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2016
Einat Almon
Protalix BioTherapeutics